SGLT2 Inhibitors and Peripheral Vascular Events
Elena Marchiori, Roman N Rodionov, Frederik Peters, Christina Magnussen, Joakim Nordanstig, Alexander Gombert, Κωνσταντίνος Σπανός, Natalia Jarzebska, Christian‐Alexander Behrendt
Topics & Concepts
MedicineObservational studyCanagliflozinRandomized controlled trialAmputationPeripheralInternal medicinePeripheral edemaClinical trialHeart failureArterial diseaseIntensive care medicineDiabetes mellitusSurgeryVascular diseaseAdverse effectEndocrinologyType 2 diabetesDiabetes Treatment and ManagementPharmacology and Obesity TreatmentAntiplatelet Therapy and Cardiovascular Diseases